Fürüzan Köktürk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fürüzan Köktürk has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Selda Sarikaya
Zonguldak Bülent Ecevit University
3 shared publications - Şenay Özdolap
Bulent Ecevit University Faculty of Medicine
3 shared publications - Ali Can Önal
Zonguldak Bülent Ecevit University, Faculty of Medicine, Department of Pathology, Zonguldak, Turkey
2 shared publications - Alper Mengi
Department of Pain Management Sultan 1. Murat State Hospital Edirne Turkey
2 shared publications - Aybüke Nazlı Aydemir Geren
Zonguldak Bülent Ecevit University, Faculty of Medicine, Department of Dermatology, Zonguldak, Turkey
2 shared publications - Banu Alicioglu
Radiology Department, Faculty of Medicine, Zonguldak Bulent Ecevit University, Kozlu, Turkey
2 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Springer Nature in Techniques in Coloproctology
Functional outcomes after transperineal anterior levatorplasty for symptomatic rectocele with perineal descent: a retrospective study
- 17 November 2026
- Published by Springer Nature in Techniques in Coloproctology
Open AccessFunctional outcomes after transperineal anterior levatorplasty for symptomatic rectocele with perineal descent: a retrospective study
- Open Access
- 29 October 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (4) , 7611
Stage-Specific Dermoscopic Patterns in Kaposi Sarcoma: A Retrospective Clinicodermoscopic Study
Introduction: Kaposi sarcoma (KS) is an angioproliferative neoplasm driven by HHV-8 infection that exhibits variable clinical morphology across stages. Dermoscopy offers a noninvasive tool to capture the evolving structural changes in these lesions. Objectives: This study aimed to characterize dermoscopic patterns of KS according to clinical stage and to correlate these findings with histopathological features. Methods: A retrospective analysis was conducted on 254 dermoscopically-documented KS lesions from 32 patients diagnosed between 2020 and 2024. Dermoscopic images were evaluated independently by two observers following the International Dermoscopy Society terminology. Statistical comparisons across patch, plaque, and nodular stages were performed using chi-square tests with Bonferroni correction. Results: Surface scale (75.2%) was the most common dermoscopic feature and increased significantly with advancing clinical stage (P=0.022). Polychromatic color change, collarette sign, ulceration, fiber sign, and blood spots were predominantly observed in plaque and nodular stages (P<0.001 for all). In contrast, pigment-related structures, particularly brown reticular lines and brown structureless areas (P<0.001), and four-dot clods (P=0.018) were significantly more frequent in patch lesions. Histopathologically, polychromatic color change corresponded to slit-like vascular spaces, erythrocyte extravasation, and hyaline globules, whereas pigment-related structures were associated with basal epidermal melanin and dermal hemosiderin deposition. Conclusions: Dermoscopic features of KS vary significantly with clinical stage and parallel histopathological progression. Recognition of these stage-specific patterns may enhance the non-invasive assessment of KS and aid clinical differentiation from other vascular and pigmented tumors.
- 29 October 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (4) , 7611
Open AccessStage-Specific Dermoscopic Patterns in Kaposi Sarcoma: A Retrospective Clinicodermoscopic Study
Introduction: Kaposi sarcoma (KS) is an angioproliferative neoplasm driven by HHV-8 infection that exhibits variable clinical morphology across stages. Dermoscopy offers a noninvasive tool to capture the evolving structural changes in these lesions. Objectives: This study aimed to characterize dermoscopic patterns of KS according to clinical stage and to correlate these findings with histopathological features. Methods: A retrospective analysis was conducted on 254 dermoscopically-documented KS lesions from 32 patients diagnosed between 2020 and 2024. Dermoscopic images were evaluated independently by two observers following the International Dermoscopy Society terminology. Statistical comparisons across patch, plaque, and nodular stages were performed using chi-square tests with Bonferroni correction. Results: Surface scale (75.2%) was the most common dermoscopic feature and increased significantly with advancing clinical stage (P=0.022). Polychromatic color change, collarette sign, ulceration, fiber sign, and blood spots were predominantly observed in plaque and nodular stages (P<0.001 for all). In contrast, pigment-related structures, particularly brown reticular lines and brown structureless areas (P<0.001), and four-dot clods (P=0.018) were significantly more frequent in patch lesions. Histopathologically, polychromatic color change corresponded to slit-like vascular spaces, erythrocyte extravasation, and hyaline globules, whereas pigment-related structures were associated with basal epidermal melanin and dermal hemosiderin deposition. Conclusions: Dermoscopic features of KS vary significantly with clinical stage and parallel histopathological progression. Recognition of these stage-specific patterns may enhance the non-invasive assessment of KS and aid clinical differentiation from other vascular and pigmented tumors.
- Open Access
- 5 October 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16, 7611
Stage-Specific Dermoscopic Patterns in Kaposi Sarcoma: A Retrospective Clinicodermoscopic Study
Introduction: Kaposi sarcoma (KS) is an angioproliferative neoplasm driven by HHV-8 infection that exhibits variable clinical morphology across stages. Dermoscopy offers a noninvasive tool to capture the evolving structural changes in these lesions. Objectives: This study aimed to characterize dermoscopic patterns of KS according to clinical stage and to correlate these findings with histopathological features. Methods: A retrospective analysis was conducted on 254 dermoscopically-documented KS lesions from 32 patients diagnosed between 2020 and 2024. Dermoscopic images were evaluated independently by two observers following the International Dermoscopy Society terminology. Statistical comparisons across patch, plaque, and nodular stages were performed using chi-square tests with Bonferroni correction. Results: Surface scale (75.2%) was the most common dermoscopic feature and increased significantly with advancing clinical stage (P=0.022). Polychromatic color change, collarette sign, ulceration, fiber sign, and blood spots were predominantly observed in plaque and nodular stages (P<0.001 for all). In contrast, pigment-related structures, particularly brown reticular lines and brown structureless areas (P<0.001), and four-dot clods (P=0.018) were significantly more frequent in patch lesions. Histopathologically, polychromatic color change corresponded to slit-like vascular spaces, erythrocyte extravasation, and hyaline globules, whereas pigment-related structures were associated with basal epidermal melanin and dermal hemosiderin deposition. Conclusions: Dermoscopic features of KS vary significantly with clinical stage and parallel histopathological progression. Recognition of these stage-specific patterns may enhance the non-invasive assessment of KS and aid clinical differentiation from other vascular and pigmented tumors.
- 5 October 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16, 7611
Open AccessStage-Specific Dermoscopic Patterns in Kaposi Sarcoma: A Retrospective Clinicodermoscopic Study
Introduction: Kaposi sarcoma (KS) is an angioproliferative neoplasm driven by HHV-8 infection that exhibits variable clinical morphology across stages. Dermoscopy offers a noninvasive tool to capture the evolving structural changes in these lesions. Objectives: This study aimed to characterize dermoscopic patterns of KS according to clinical stage and to correlate these findings with histopathological features. Methods: A retrospective analysis was conducted on 254 dermoscopically-documented KS lesions from 32 patients diagnosed between 2020 and 2024. Dermoscopic images were evaluated independently by two observers following the International Dermoscopy Society terminology. Statistical comparisons across patch, plaque, and nodular stages were performed using chi-square tests with Bonferroni correction. Results: Surface scale (75.2%) was the most common dermoscopic feature and increased significantly with advancing clinical stage (P=0.022). Polychromatic color change, collarette sign, ulceration, fiber sign, and blood spots were predominantly observed in plaque and nodular stages (P<0.001 for all). In contrast, pigment-related structures, particularly brown reticular lines and brown structureless areas (P<0.001), and four-dot clods (P=0.018) were significantly more frequent in patch lesions. Histopathologically, polychromatic color change corresponded to slit-like vascular spaces, erythrocyte extravasation, and hyaline globules, whereas pigment-related structures were associated with basal epidermal melanin and dermal hemosiderin deposition. Conclusions: Dermoscopic features of KS vary significantly with clinical stage and parallel histopathological progression. Recognition of these stage-specific patterns may enhance the non-invasive assessment of KS and aid clinical differentiation from other vascular and pigmented tumors.
- 13 July 2026
- Published by Elsevier in Clinical Imaging
- Vol. 138, 110899
Association of indexed pericardial fat volume with coronary plaque burden and plaque composition in patients with non-obstructive coronary artery disease
- 13 July 2026
- Published by Elsevier in Clinical Imaging
- Vol. 138, 110899
Association of indexed pericardial fat volume with coronary plaque burden and plaque composition in patients with non-obstructive coronary artery disease
- Open Access
- 19 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (25) , e49314
Predictive value of a clinical score for overall survival following curative radiotherapy for lung cancer
This study retrospectively calculated the LabPS score (laboratory parameters + performance status) in patients with small-cell lung cancer (SCLC) and non-SCLC who were treated with curative radiotherapy. The score was derived from pretreatment laboratory parameters – including hemoglobin level, platelet count, serum lactate dehydrogenase, serum albumin, and serum C-reactive protein – and Eastern Cooperative Oncology Group (ECOG) performance status (PS). The primary aim was to investigate the association between the LabPS score and overall survival (OS). The LabPS score was calculated retrospectively by reviewing pretreatment routine complete blood counts, biochemistry results, and ECOG PS of patients diagnosed with lung cancer and treated with radiotherapy. Patients who underwent radiotherapy with curative intent were selected. Patients with metastatic lung cancer and ECOG PS ≥ 3 were excluded. The primary endpoint was determined as OS. When LabPS scores were evaluated using receiver operating characteristic curve analysis, patients were classified into 2 prognostic groups: “favorable” (≤1) and “unfavorable” (>1), with an area under the curve corresponding to a 95% confidence interval: 0.654 to 0.806. Patients were stratified according to both their TNM stage and LabPS score, and survival analyses were subsequently conducted. These analyses demonstrated that patients with early-stage disease and a favorable LabPS score had significantly longer OS. In this study, the LabPS score successfully stratified patients with SCLC and non-SCLC into prognostic groups, demonstrating significant survival differences between the favorable and unfavorable categories. These findings suggest that the LabPS score has potential for survival prediction. Because the LabPS score can be easily calculated using routine laboratory tests in combination with PS, it has the potential to serve as a practical and cost-effective tool in daily oncology practice, pending further validation in larger, prospective cohorts. If validated in future studies, this score may potentially assist in clinical decision-making, including the timing of chemoradiotherapy, radiation dose optimization, and the development of personalized treatment plans.
- 19 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (25) , e49314
Open AccessPredictive value of a clinical score for overall survival following curative radiotherapy for lung cancer
This study retrospectively calculated the LabPS score (laboratory parameters + performance status) in patients with small-cell lung cancer (SCLC) and non-SCLC who were treated with curative radiotherapy. The score was derived from pretreatment laboratory parameters – including hemoglobin level, platelet count, serum lactate dehydrogenase, serum albumin, and serum C-reactive protein – and Eastern Cooperative Oncology Group (ECOG) performance status (PS). The primary aim was to investigate the association between the LabPS score and overall survival (OS). The LabPS score was calculated retrospectively by reviewing pretreatment routine complete blood counts, biochemistry results, and ECOG PS of patients diagnosed with lung cancer and treated with radiotherapy. Patients who underwent radiotherapy with curative intent were selected. Patients with metastatic lung cancer and ECOG PS ≥ 3 were excluded. The primary endpoint was determined as OS. When LabPS scores were evaluated using receiver operating characteristic curve analysis, patients were classified into 2 prognostic groups: “favorable” (≤1) and “unfavorable” (>1), with an area under the curve corresponding to a 95% confidence interval: 0.654 to 0.806. Patients were stratified according to both their TNM stage and LabPS score, and survival analyses were subsequently conducted. These analyses demonstrated that patients with early-stage disease and a favorable LabPS score had significantly longer OS. In this study, the LabPS score successfully stratified patients with SCLC and non-SCLC into prognostic groups, demonstrating significant survival differences between the favorable and unfavorable categories. These findings suggest that the LabPS score has potential for survival prediction. Because the LabPS score can be easily calculated using routine laboratory tests in combination with PS, it has the potential to serve as a practical and cost-effective tool in daily oncology practice, pending further validation in larger, prospective cohorts. If validated in future studies, this score may potentially assist in clinical decision-making, including the timing of chemoradiotherapy, radiation dose optimization, and the development of personalized treatment plans.
- Open Access
- 30 April 2025
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
- Vol. 12 (1) , 21-26
An Investigation of TRIM36 Expression in Breast Cancer
Breast cancer is the most frequently diagnosed cancer type worldwide and ranks 2nd among cancers that cause death. While the role of TRIM36 has been investigated in certain human cancers, such as prostate and lung cancer, its functions remain largely unexplored. In this study, the expression level of TRIM36, whose role in breast cancer has not been previously examined, and its potential association with breast cancer pathogenesis were analyzed. RNA was isolated from normal and tumor tissues of 45 breast cancer patients. Complementary DNA (cDNA) was synthesized from the RNA, and mRNA expression levels of GAPDH and TRIM36 were quantified using qRT-PCR. TRIM36 expression was observed in breast tissues; however, no statistically significant difference was found in TRIM36 mRNA expression levels, normalized to GAPDH, between normal and tumor tissues (p=0.731). Although this study suggests that TRIM36 gene expression levels in breast cancer tissues do not differ from normal tissues, the limited sample size highlights the need for more comprehensive studies to elucidate the relationship between the TRIM36 gene and breast cancer.
- 30 April 2025
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
- Vol. 12 (1) , 21-26
Open AccessAn Investigation of TRIM36 Expression in Breast Cancer
Breast cancer is the most frequently diagnosed cancer type worldwide and ranks 2nd among cancers that cause death. While the role of TRIM36 has been investigated in certain human cancers, such as prostate and lung cancer, its functions remain largely unexplored. In this study, the expression level of TRIM36, whose role in breast cancer has not been previously examined, and its potential association with breast cancer pathogenesis were analyzed. RNA was isolated from normal and tumor tissues of 45 breast cancer patients. Complementary DNA (cDNA) was synthesized from the RNA, and mRNA expression levels of GAPDH and TRIM36 were quantified using qRT-PCR. TRIM36 expression was observed in breast tissues; however, no statistically significant difference was found in TRIM36 mRNA expression levels, normalized to GAPDH, between normal and tumor tissues (p=0.731). Although this study suggests that TRIM36 gene expression levels in breast cancer tissues do not differ from normal tissues, the limited sample size highlights the need for more comprehensive studies to elucidate the relationship between the TRIM36 gene and breast cancer.
- 28 April 2022
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 6 (1) , 72-77
Biyolojik DMARD Kullanan Hastalarda Kronik Hepatit B Enfeksiyonu ve Okkült Hepatit B Sıklığı ve Tedavi Yönetimi
Amaç: Biyolojik hastalık modifiye edici ilaç (bDMARDs) kullanan hastaların (romatoid artrit, ankilozan spondilit ve psöriatik artrit) Hepatit B virüs (HBV) reaktivasyonu, kronik ve okkült HBV varlığını araştırmayı hedefledik. Gereç ve Yöntemler: Zonguldak Bülent Ecevit Üniversitesi Sağlık Uygulama Araştırma Hastanesi Fiziksel Tıp ve Rehabilitasyon kliniğinde takip edilen ve biyolojik DMARDs (infliksimab, adalimumab, etanercept, golimumab, sertolizumab, tofasitinib, sekukinumab, tosilizumab, ustekinumab) kullanan hastaların dosyalarında yer alan verileri retrospektif olarak incelendi. Hastaların yaşı, cinsiyeti, tanıları (romatoid artrit, ankilozan spondilit ve psöriatik artrit), kullanmakta olduğu ilaçlar, kullanım süreleri, Hepatit B antijen ve antikorları (HBsAg, anti-HBs ve anti-HBc IgG) ve HBV için ilaç kullanmakta olan hastalar kaydedildi. Bulgular: Çalışmaya 138 hasta dahil edildi. Hastaların 64’ü (%46,4) kadın ve 74’ü (%53,6) erkekti. Ortalama yaşları 47,7±11,9 yıl olarak hesaplandı. Olguların dördünde (%2,9) HBsAg 47 (%34,8)’sinde anti-HBc IgG ve 63 (%45,6)’ünde anti-HBs pozitifliği vardı. Hastaların 32 (%23,2)’si antiviral tedavi almaktaydı. Anti HBc-Ig G(+) olan 15 (%10,8) olgu antiviral tedavisizdi ve üç aylık HBV DNA izlemleri ile takip edilmekteydi. Toplam 16 (%11,5) olgu Hepatit B’ye karşı aşılıydı. Sonuç: Çalışma sonucunda bDMARD kullanan kronik ve okkült HBV yönünden 47 olgunun ortalama beş yıllık tedavi ve klinik izleminde HBV reaktivasyonu görülmedi. Biyolojik DMARDs kullananlarda sıkı takip ve uygun protokolle HBV reaktivasyonu gibi korkulan bir komplikasyon gelişmeyebilir.
- 28 April 2022
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 6 (1) , 72-77
Biyolojik DMARD Kullanan Hastalarda Kronik Hepatit B Enfeksiyonu ve Okkült Hepatit B Sıklığı ve Tedavi Yönetimi
Amaç: Biyolojik hastalık modifiye edici ilaç (bDMARDs) kullanan hastaların (romatoid artrit, ankilozan spondilit ve psöriatik artrit) Hepatit B virüs (HBV) reaktivasyonu, kronik ve okkült HBV varlığını araştırmayı hedefledik. Gereç ve Yöntemler: Zonguldak Bülent Ecevit Üniversitesi Sağlık Uygulama Araştırma Hastanesi Fiziksel Tıp ve Rehabilitasyon kliniğinde takip edilen ve biyolojik DMARDs (infliksimab, adalimumab, etanercept, golimumab, sertolizumab, tofasitinib, sekukinumab, tosilizumab, ustekinumab) kullanan hastaların dosyalarında yer alan verileri retrospektif olarak incelendi. Hastaların yaşı, cinsiyeti, tanıları (romatoid artrit, ankilozan spondilit ve psöriatik artrit), kullanmakta olduğu ilaçlar, kullanım süreleri, Hepatit B antijen ve antikorları (HBsAg, anti-HBs ve anti-HBc IgG) ve HBV için ilaç kullanmakta olan hastalar kaydedildi. Bulgular: Çalışmaya 138 hasta dahil edildi. Hastaların 64’ü (%46,4) kadın ve 74’ü (%53,6) erkekti. Ortalama yaşları 47,7±11,9 yıl olarak hesaplandı. Olguların dördünde (%2,9) HBsAg 47 (%34,8)’sinde anti-HBc IgG ve 63 (%45,6)’ünde anti-HBs pozitifliği vardı. Hastaların 32 (%23,2)’si antiviral tedavi almaktaydı. Anti HBc-Ig G(+) olan 15 (%10,8) olgu antiviral tedavisizdi ve üç aylık HBV DNA izlemleri ile takip edilmekteydi. Toplam 16 (%11,5) olgu Hepatit B’ye karşı aşılıydı. Sonuç: Çalışma sonucunda bDMARD kullanan kronik ve okkült HBV yönünden 47 olgunun ortalama beş yıllık tedavi ve klinik izleminde HBV reaktivasyonu görülmedi. Biyolojik DMARDs kullananlarda sıkı takip ve uygun protokolle HBV reaktivasyonu gibi korkulan bir komplikasyon gelişmeyebilir.
- Open Access
- 28 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1406-1412
The effect of weather variables on the severity, duration, and frequency of headache attacks in the cases of episodic migraine and episodic tension-type headache
The effect of weather variables on the severity, duration and frequency of headache attacks in the cases of episodic migraine and episodic tension-type headache Abstract Background/aim: Although many headache patients report that the frequency and severity of attacks vary according to the season or weather in clinical practice, the relationship between the characteristics of the attacks and the weather is not very clear in episodic headaches. We aimed to compare the effects of weather variables (temperature, wind speed, wind direction, humidity, pressure, ultraviolet index and sunshine duration) on episodic migraine (EM) and episodic tension-type headache (ETTH) attacks (incidence, duration and severity). Fifty patients with EM and fifty patients with ETTH diagnosed according to International Classification of Headache Disorders-II are included in the study. Patients were given one diary for headache follow-up. The evaluation form on the relationship between the duration, frequency and severity of the pain and the findings obtained from the headache diaries were compared with the daily weather data and the two headache groups were compared with each other in terms of the effect of meteorological data on the pain characteristics. It is determined that mean wind velocity in EM attacks is significantly higher when compared to the tension-type headache (TTH) attacks and mean UV index is significantly higher in TTH attacks (p=0.018 and 0.039 ). Mean UV index in TTH attack days was reported higher in women than men (p=0.044). Mean sunshine duration in TTH attack days was reported longer in women than men (p=0.050). When mean age gets higher in patients with migraine, mean temperature in the days of attack gets lower (r=-0.146 and p=0.046). During the treatment of migraine and TTH patients, recommendations and warnings about weather conditions can be made. This information can guide patients to regulate their daily living activities. The importance of considering the weather-headache relationship during the review of the current treatment in cases of unresponsiveness to treatment should be kept in mind.
- 28 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1406-1412
Open AccessThe effect of weather variables on the severity, duration, and frequency of headache attacks in the cases of episodic migraine and episodic tension-type headache
The effect of weather variables on the severity, duration and frequency of headache attacks in the cases of episodic migraine and episodic tension-type headache Abstract Background/aim: Although many headache patients report that the frequency and severity of attacks vary according to the season or weather in clinical practice, the relationship between the characteristics of the attacks and the weather is not very clear in episodic headaches. We aimed to compare the effects of weather variables (temperature, wind speed, wind direction, humidity, pressure, ultraviolet index and sunshine duration) on episodic migraine (EM) and episodic tension-type headache (ETTH) attacks (incidence, duration and severity). Fifty patients with EM and fifty patients with ETTH diagnosed according to International Classification of Headache Disorders-II are included in the study. Patients were given one diary for headache follow-up. The evaluation form on the relationship between the duration, frequency and severity of the pain and the findings obtained from the headache diaries were compared with the daily weather data and the two headache groups were compared with each other in terms of the effect of meteorological data on the pain characteristics. It is determined that mean wind velocity in EM attacks is significantly higher when compared to the tension-type headache (TTH) attacks and mean UV index is significantly higher in TTH attacks (p=0.018 and 0.039 ). Mean UV index in TTH attack days was reported higher in women than men (p=0.044). Mean sunshine duration in TTH attack days was reported longer in women than men (p=0.050). When mean age gets higher in patients with migraine, mean temperature in the days of attack gets lower (r=-0.146 and p=0.046). During the treatment of migraine and TTH patients, recommendations and warnings about weather conditions can be made. This information can guide patients to regulate their daily living activities. The importance of considering the weather-headache relationship during the review of the current treatment in cases of unresponsiveness to treatment should be kept in mind.
- 23 January 2020
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 39 (7) , 1327-1333
Effects of Therapeutic Ultrasound Applied to the Lumbar Region on Renal Function
Objectives: Therapeutic ultrasound (TUS) is one of the most commonly used modalities in low back pain treatment. The objective of this study was to determine whether TUS applied to the low back region in patients with chronic low back pain had any effect on renal function.Methods: Forty patients with chronic low back pain were randomized to 2 groups by a block randomization method. Thirty‐seven patients completed the final evaluation. All patients were treated for 5 sessions per week for 3 weeks with the same physiotherapy modalities (superficial heating and transcutaneous electrical nerve stimulation) and exercise therapy; in addition to these treatments, the second group was treated with TUS for 10 minutes (frequency, 1 MHz; intensity, 1.5 W/cm2; and effective irradiation area of the transducer head, 5 cm2). The serum creatinine, serum cystatin C, 24‐hour urine creatinine, creatinine clearance, 24‐hour urine microalbumin and microprotein, urine volume, and glomerular filtration rate were measured. The patients were evaluated at baseline (day 0) and the end of the treatment (day 21).Results: The serum cystatin C levels were increased in both groups, but this increase was not significant (P > .05). There was no difference between the groups in the percent change in all outcome measures (P > .05).Conclusions: This showed that TUS applied to the low back region does not affect renal function.
- 23 January 2020
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 39 (7) , 1327-1333
Effects of Therapeutic Ultrasound Applied to the Lumbar Region on Renal Function
Objectives: Therapeutic ultrasound (TUS) is one of the most commonly used modalities in low back pain treatment. The objective of this study was to determine whether TUS applied to the low back region in patients with chronic low back pain had any effect on renal function.Methods: Forty patients with chronic low back pain were randomized to 2 groups by a block randomization method. Thirty‐seven patients completed the final evaluation. All patients were treated for 5 sessions per week for 3 weeks with the same physiotherapy modalities (superficial heating and transcutaneous electrical nerve stimulation) and exercise therapy; in addition to these treatments, the second group was treated with TUS for 10 minutes (frequency, 1 MHz; intensity, 1.5 W/cm2; and effective irradiation area of the transducer head, 5 cm2). The serum creatinine, serum cystatin C, 24‐hour urine creatinine, creatinine clearance, 24‐hour urine microalbumin and microprotein, urine volume, and glomerular filtration rate were measured. The patients were evaluated at baseline (day 0) and the end of the treatment (day 21).Results: The serum cystatin C levels were increased in both groups, but this increase was not significant (P > .05). There was no difference between the groups in the percent change in all outcome measures (P > .05).Conclusions: This showed that TUS applied to the low back region does not affect renal function.
- Open Access
- 1 January 2020
- Vol. 66 (3) , 252-261
Comparison of effectiveness of different kinesiological taping techniques in patients with chronic low back pain: A double-blind, randomized-controlled study
This study aims to investigate the effects of kinesiological taping (KT) method combined with physiotherapy modalities and exercise therapy on the severity of pain, range of lumbar motion, and degree of disability. Between November 2015 and November 2016, a total of 125 patients (63 males, 62 females; mean age 45 years; range, 20 to 65 years) who were diagnosed with chronic non-specific low back pain were included in this double-blind, randomized, placebo-controlled study. The patients were randomly assigned to four groups. All groups received the same physiotherapy modalities and exercise therapy. Group 1 received physiotherapy modalities and exercise therapy alone; Group 2 received additional sham KT; Group 3 received additional KT with a space correction technique; and Group 4 received additional KT with a fascia correction technique. Kinesiological taping was applied for three weeks with five-day intervals and four times in total. The patients were evaluated at baseline (Day 0), at the end of the treatment (Day 21), and on Day 51. Pain severity using the Visual Analog Scale (VAS), ranges of lumbar motion using the fingertip-to-floor distances and modified lumbar Schober test, and the degree of disability using the Oswestry Disability Index (ODI) and Roland Morris Disability Questionnaire (RMDQ) were evaluated. We found a significant difference among the groups in terms of VAS motion T0-51 changes (p<0.05). There was also a significant difference among the groups in terms of T0-21 and T0-51 changes in the ODI and RMDQ (p<0.05). Our study results suggest that KT ensures reduction in pain and disability, irrespective of the technique of taping, with sustainable short-term effects following the end of the treatment.
- 1 January 2020
- Vol. 66 (3) , 252-261
Open AccessComparison of effectiveness of different kinesiological taping techniques in patients with chronic low back pain: A double-blind, randomized-controlled study
This study aims to investigate the effects of kinesiological taping (KT) method combined with physiotherapy modalities and exercise therapy on the severity of pain, range of lumbar motion, and degree of disability. Between November 2015 and November 2016, a total of 125 patients (63 males, 62 females; mean age 45 years; range, 20 to 65 years) who were diagnosed with chronic non-specific low back pain were included in this double-blind, randomized, placebo-controlled study. The patients were randomly assigned to four groups. All groups received the same physiotherapy modalities and exercise therapy. Group 1 received physiotherapy modalities and exercise therapy alone; Group 2 received additional sham KT; Group 3 received additional KT with a space correction technique; and Group 4 received additional KT with a fascia correction technique. Kinesiological taping was applied for three weeks with five-day intervals and four times in total. The patients were evaluated at baseline (Day 0), at the end of the treatment (Day 21), and on Day 51. Pain severity using the Visual Analog Scale (VAS), ranges of lumbar motion using the fingertip-to-floor distances and modified lumbar Schober test, and the degree of disability using the Oswestry Disability Index (ODI) and Roland Morris Disability Questionnaire (RMDQ) were evaluated. We found a significant difference among the groups in terms of VAS motion T0-51 changes (p<0.05). There was also a significant difference among the groups in terms of T0-21 and T0-51 changes in the ODI and RMDQ (p<0.05). Our study results suggest that KT ensures reduction in pain and disability, irrespective of the technique of taping, with sustainable short-term effects following the end of the treatment.